研究成果・実績

Long-acting injectable versus oral antipsychotics for schizophrenia – Authors’ reply.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Lancet Psychiatry. 2021 Jul;8(7):567.

Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy.

Opel N, Narr KL, Abbott C, Argyelan M, Espinoza R, Emsell L, Bouckaert F, Sienaert P, Vandenbulcke M, Nordanskog P, Repple J, Kavakbasi E, Jorgensen MB, Paulson OB,DMSc12; Lars G. Hanson, Dols A, van Exel E, Oudega ML, Takamiya A, Kishimoto T, Ousdal OT, Haavik J, Hammar Å, Oedegaard KJ, Kessler U, Bartsch H, Dale AM, Baune BT, Dannlowski U, Oltedal L, Redlich R. J Psychiatry Neurosci. 2021 Jul 5;46(4):E418-E426.

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206.

Fecal Microbial and Metabolomic Change during treatment course for depression: An Observational Study.

Kurokawa S, Tomizawa Y, Miyaho K, Ishii D, Takamiya A, Ishii C, Sanada K, Fukuda S, Mimura M, Kishimoto T. J Psychiatr Res. 2021 May 8;140:45-52.

Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity.

Chou PH, Lin YF, Lu MK, Chang HA, Chu CS, Chang WH, Kishimoto T, Sack AT, Su KP. Clin Psychopharmacol Neurosci. 2021 May 31;19(2):190-205.

Unobtrusive Sensing Technology for Quantifying Stress and Well-Being Using Pulse, Speech, Body Motion, and Electrodermal Data in a Workplace Setting: Study Concept and Design.

Izumi K, Minato K, Shiga K, Sugio T, Hanashiro S, Cortright K, Kudo S, Fujita T, Sado M, Maeno T, Takebayashi T, Mimura M, Kishimoto T. Front Psychiatry. 2021 Apr 28;12:611243.

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Lancet Psychiatry. 2021 May;8(5):387-404.

Cognitive Intervention Through Photo-Integrated Conversation Moderated by Robots (PICMOR) Program: A Randomized Controlled Trial.

Otake-Matsuura M, Tokunaga S, Watanabe K, Abe MS, Sekiguchi T, Sugimoto H, Kishimoto T, Kudo T. Front Robot AI. 2021 Apr 12;8:633076.

Effects of Psychotropics on the Microbiome in Patients With Depression and Anxiety: Considerations in a Naturalistic Clinical Setting. Int J Neuropsychopharmacol.

Tomizawa Y, Kurokawa S, Ishii D, Miyaho K, Ishii C, Sanada K, Fukuda S, Mimura M, Kishimoto T. 2021 Feb 15;24(2):97-107.

Electroconvulsive Therapy for Parkinson’s Disease: A Systematic Review and Meta-Analysis.

Takamiya A, Seki M, Kudo S, Yoshizaki T, Nakahara J, Mimura M, Kishimoto T. Mov Disord. 2021 Jan;36(1):50-58.